ALVEOLITIS FIBROSING

ALVEOLITIS FIBROSING was reported 109 times

ALVEOLITIS FIBROSING is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interferon gamma [EPC] 1 0.0007
1 Purine Antimetabolite [EPC] 15 0.0002
2 Prostaglandin E1 Analog [EPC] 2 0.0001
3 CD52-directed Cytolytic Antibody [EPC] 2 0.0001
4 Aminosalicylate [EPC] 6 0.0001
5 Folate Analog Metabolic Inhibitor [EPC] 21 0.0000
6 Antimycobacterial [EPC] 1 0.0000
7 Proton Pump Inhibitor [EPC] 22 0.0000
8 Nucleoside Analog Antiviral [EPC] 3 0.0000
9 Tumor Necrosis Factor Blocker [EPC] 34 0.0000
10 Antirheumatic Agent [EPC] 3 0.0000
11 Tetracycline-class Drug [EPC] 2 0.0000
12 Corticosteroid [EPC] 27 0.0000
13 Vitamin D [EPC] 6 0.0000
14 Platelet Aggregation Inhibitor [EPC] 11 0.0000
15 Vitamin B12 [EPC] 6 0.0000
16 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
17 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
18 Vitamin C [EPC] 7 0.0000
19 beta-Adrenergic Blocker [EPC] 5 0.0000
20 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
21 Loop Diuretic [EPC] 7 0.0000
22 Cardiac Glycoside [EPC] 1 0.0000
23 HER2/neu Receptor Antagonist [EPC] 1 0.0000
24 Nonsteroidal Anti-inflammatory Drug [EPC] 17 0.0000
25 Dihydropyridine Calcium Channel Blocker [EPC] 4 0.0000
26 Nitrate Vasodilator [EPC] 1 0.0000
27 HMG-CoA Reductase Inhibitor [EPC] 4 0.0000
28 Osmotic Laxative [EPC] 3 0.0000
29 Parathyroid Hormone Analog [EPC] 1 0.0000
30 Fluoroquinolone Antibacterial [EPC] 1 0.0000
31 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
32 alpha-Adrenergic Blocker [EPC] 1 0.0000
33 Azole Antifungal [EPC] 1 0.0000
34 Microtubule Inhibitor [EPC] 1 0.0000
35 Alkylating Drug [EPC] 1 0.0000
36 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
37 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
38 Insulin Analog [EPC] 1 0.0000
39 Benzodiazepine [EPC] 1 0.0000